Chemical compound lights up treatment-resistant cancers on imaging scans

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.

Redo TAVR procedures are safe and effective, study shows

Cedars-Sinai investigators are leaders in the innovation and use of transcatheter aortic valve replacement (TAVR) with balloon-expandable valves.

September 1, 2023

Study reveals new H5N1 variants evade human antibodies more effectively

In a new study led by UNC Charlotte researchers from the Center for Computational Intelligence to Predict Health and Environmental Risks (CIPHER) and the North

August 2, 2024

Halia plans two trials testing its anti-inflammatory lead candidate – Pharmaceutical Technology

Halia also wants to run a second Phase II trial that will test HT-6184’s ability to address the inflammatory response to wisdom tooth extraction. Credit:

August 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.